Universitätsklinikum Düsseldorf

Hospital


Location: Düsseldorf, Germany (DE) DE

ISNI: 0000000089227789

ROR: https://ror.org/006k2kk72

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial (2025) Bergmann L, Albiges L, Ahrens M, Gross-Goupil M, Boleti E, Gravis G, Fléchon A, et al. Journal article Changes in Chronic Graft-versus-Host Disease Treatment Over Time: A 15-Years Survey Within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland (2025) Denk A, Fante MA, Heidenreich S, Greinix HT, Drouet EMW, Egger-Heidrich K, Marx J, et al. Journal article Balancing barriers: Family, career, and gender equality in radiation oncology and radiation research—An interdisciplinary prospective survey among the young workforce (2025) Trommer M, Grohmann M, Fabian A, Ehret F, Hess J, Rückert M, Matschke J, et al. Journal article Disease Characteristics and Treatments Associated with Outcome in Primary Angiitis of the Central Nervous System—A Multicenter Cohort Study in 163 Patients (2025) Fisse AL, Bonberg N, Beuker C, Pfeuffer C, Heidenreich A, Krüger C, Deb-Chatterji M, et al. Journal article Matrix stiffness regulates profibrotic fibroblast differentiation and fibrotic niche activation in systemic sclerosis (2025) Ueberall L, Mohammadian H, Demmler R, Ariza Y, Tripal P, Anchang CG, Weber S, et al. Journal article VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AML (2025) Kretschmer L, Ruhnke L, Schliemann C, Fransecky L, Steffen B, Kaufmann M, Burchert A, et al. Journal article Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer (2024) Fasching P, Hu C, Hart SN, Rübner M, Polley EC, Gnanaolivu RD, Hartkopf AD, et al. Journal article The role of mesolevel characteristics of the health care system and socioeconomic factors on health care use – results of a scoping review (2024) Bammert P, Schüttig W, Novelli A, Iashchenko I, Spallek J, Blume M, Diehl K, et al. Journal article Corrigendum to “Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations” [Eur J Cancer 207 (2024) 114158](S0959804924008141)(10.1016/j.ejca.2024.114158) (2024) Kron A, Scheffler M, Wiesweg M, Hummel HD, Kulhavy J, Gatteloehner S, Kollmeier J, et al. Journal article, Erratum Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy (2024) Merz M, Dima D, Hashmi H, Ahmed N, Stölzel F, Holderried TA, Fenk R, et al. Journal article